OptiNose (NASDAQ: OPTN) reported Q4 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $20.86 million versus the consensus estimate of $20.69 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.